Business Line Product Steward - Product Stewardship

Luis Fernandez-Moreno elected to Celanese Board of Directors. DALLAS, Sept 17 -Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced that Luis Fernandez-Moreno has been elected to the Company's Board of Directors. A seasoned public and private company director, Mr. Fernandez-Moreno, 64, currently serves on the boards of Ingevity Corporation, a global specialty materials company, where he has been a director since 2016 and served as interim President and CEO from October 2024 to April 2025, and Select Water Solutions, a provider of sustainable water and chemical solutions to the energy industry. He brings over 40 years of experience and leadership in the performance materials, specialty ingredients and coatings industries across North America, Latin America and Europe. His background spans corporate strategy, growth and innovation, and mergers and acquisitions, giving him a broad perspective on managing global chemicals businesses. He will join the Celanese Board effective September 16, 2026, bringing the total number of Board members to 11 (10 of whom are independent). Mr. Fernandez-Moreno served as Senior Vice President at Ashland, Inc. from 2013 to 2017 as President of the Chemicals Group and of Specialty Ingredients. Prior to that role, he served as the President of Ashland's Water Technologies business. Before joining Ashland, he was Executive Vice President at Arch Chemicals, responsible for the HTH Water Products and the Wood Protection businesses. Following The Dow Chemical Company's acquisition of Rohm & Haas Company, where he served in positions of increasing responsibility for 25 years, Fernandez-Moreno was named Group Vice President for the newly formed Dow Coatings Materials business. Business Wire Listing Discover more Mr. Fernandez-Moreno holds a Bachelor of Science in Chemical Engineering from Universidad Iberoamericana in Mexico and is a graduate of the Wharton Management Certificate Program at the University of Pennsylvania. "We are pleased to welcome Luis to the Board," stated Ed Galante, Chair of the Board at Celanese Corporation. "Having led multibillion-dollar specialty chemicals businesses across multiple continents, Luis brings significant strategic and operational experience that is directly relevant to Celanese. His proven ability to drive profitable growth and position global businesses for long-term value creation will be instrumental as we continue to advance the Company's strategic priorities and drive value for our shareholders."

Strategic realignment: impact of diketene supply chain consolidation. The acquisition of VP4 Frankfurt by Celanese marks a shift toward vertical integration in the intermediates market. Procurement teams must now adapt to new supply pathways for diketene. On September 2, 2026, Sudarshan Chemical Industries announced the divestment of its German subsidiary, VP4 Frankfurt, to Celanese Corporation. This transaction centralises the production of diketene - a vital building block for functional food additives - directly under its primary consumer, Nutrinova. For global sourcing managers and procurement professionals, this represents a significant shift from merchant-market tolling to captive, vertically integrated supply models. This transition is not merely a transfer of assets; it is a signal of how the fine chemicals industry is pivoting to mitigate risks associated with volatile upstream supply chains. The strategic realignment of diketene supply. The chemical manufacturing landscape is currently undergoing a period of structural resetting. As noted in recent industry reporting, companies are increasingly divesting non-core assets to focus on margin durability rather than capacity expansion. The transfer of VP4 Frankfurt is a prime example of this trend. By integrating the production stream of diketene directly with Nutrinova, Celanese is effectively removing potential intermediaries from the value chain. Diketene (C4H4O2) is a highly reactive, versatile intermediate. Because of its inherent instability and hazardous nature, it is rarely transported over long distances. Historically, chemical companies utilised regional tolling facilities - like the VP4 site in Frankfurt - to process diketene locally for a wide variety of customers, ranging from pharmaceutical synthesizers to food ingredient producers. By bringing this capacity in-house, Celanese is prioritising its own production of high-value functional sweeteners and preservatives, ensuring that its proprietary processes are insulated from the fluctuations of the merchant market. For procurement teams, this consolidation changes the sourcing landscape for reactive intermediates. Historically, tolling operations allowed for greater flexibility in the merchant market. Under the new ownership structure, supply availability for independent buyers may tighten, requiring a re-evaluation of long-term contract structures. As the availability of merchant-market diketene decreases, procurement leads must anticipate inflationary pressures and potential volume caps. Tech Serve Solutions encourage sourcing managers to review their products portfolio to ensure that supply security for these critical building blocks remains consistent with internal production requirements. Failing to pivot now could lead to supply disruptions, particularly if other major players follow Celanese's lead in internalising their feedstock production. Implications for Procurement and QA/QC. When a key intermediate production site moves to a captive model, the implications for supply chain resilience are substantial. Buyers must assess whether their current procurement strategy relies on the merchant availability of molecules like diketene. The shift means that surplus capacity, which was once readily available on the open market, is now effectively reserved for internal Nutrinova operations. If your operations rely on specific chemical precursors, direct communication with your contact representative at Tech Serve Solutions is recommended to discuss potential contingency planning and secondary sourcing alternatives. Furthermore, QA/QC and R&D chemists should remain vigilant regarding potential changes in manufacturing protocols following such transitions. While the chemical identity of the intermediate remains consistent - diketene produced by one operator is chemically indistinguishable from that produced by another - changes in site management can sometimes lead to variations in the Certificate of Analysis (CoA) documentation, impurity profiles, or delivery lead times. New ownership often brings new internal auditing standards, ERP system integrations, and logistics partners. These operational shifts can inadvertently impact the consistency of technical documentation, such as the specific levels of stabilizer additives or residual solvents monitored in the CoA. Ensuring that your catalog requirements remain aligned with updated vendor specifications is an essential step in maintaining consistent product quality and regulatory compliance. Rigorous validation of incoming batches is recommended during the first six months of the transition to account for any subtle drift in analytical reporting or logistical lead-time volatility. Industry outlook: navigating structural resets. Recent analysis from PwC suggests that US and European chemical deal-making is prioritising core competency alignment over broad-scale expansion. This strategic shift is largely driven by the need for greater capital efficiency in an era of high interest rates and decarbonisation mandates. Assets like VP4 Frankfurt are no longer being operated as general-purpose service providers but as dedicated supply nodes. For buyers of functional ingredients and pigments, this rationalisation creates a bifurcated market: one side controlled by integrated majors, and the other comprised of independent specialists. Integrated majors are increasingly focused on protecting their own margins by locking down supply, while independent specialists are forced to innovate through niche applications or superior service models to remain competitive. This bifurcated market dynamic will likely result in higher premiums for "as-needed" or spot-market purchasing, as the baseline capacity for third-party production continues to shrink. Comparative analysis: integrated vs. Merchant procurement models. To better understand how your organisation can mitigate the risks of these market shifts, consider the following comparison between integrated (captive) supply chains and traditional merchant-market sourcing. | Feature | Integrated/Captive Model | Merchant-Market Model | | Supply Security | High (Primary focus on internal use) | Moderate (Dependent on market supply) | | Pricing Stability | Less volatile (Inter-company transfer) | High volatility (Market demand-driven) | | Flexibility | Low (Assets tied to one product) | High (Adaptable to multiple buyers) | | Logistical Complexity | Simple (Direct feed-in) | Complex (Transportation of hazardous goods) | | QA/QC Oversight | Proprietary (Internal standards) | Third-party (Verified against COA) | As shown in the table above, while the integrated model provides significantly higher supply security, it sacrifices the flexibility required for agile manufacturing. Most procurement organisations should look to balance their portfolio by maintaining primary captive partners for base-load volumes while retaining independent specialists to ensure supply elasticity during peak demand. To navigate this shift, it is advisable to utilise its online resources, such as the molecular weight calculator or its CAS validator, to ensure that your technical specifications remain precise when vetting new or existing supply partners. Consistency in sourcing standards - whether USP, BP, or EP grade - remains its priority, even as the global upstream supply chain adapts to these structural changes. By staying informed on these industry developments, procurement teams can better anticipate the shifts in market dynamics that influence long-term stability and product availability. The divestment of VP4 Frankfurt is likely the first of several planned consolidations within the European chemical corridor. As firms seek to "de-risk" their exposure to external vendors, the trend toward vertical integration will likely accelerate. Procurement professionals should focus on diversifying their supplier base now, prioritising transparency and early communication to protect against the inevitable narrowing of the merchant market. The future of chemical sourcing will reward those who act with foresight, ensuring their supply chains remain as robust as the molecules they require. Frequently asked questions. What is the strategic significance of the VP4 Frankfurt divestment?+ How does this acquisition affect independent procurement managers?+ What should QA/QC teams monitor following such corporate transitions?+ What is the broader trend behind this industry movement?+ Sources. * european-coatings.com - european-coatings.com * powderbulksolids.com - powderbulksolids.com * pwc.com - pwc.com supply chain fine chemicals sourcing diketene vertical integration

Sudarshan Chemical: divests VP4 Frankfurt to Celanese. Discover more Managing Personal Wealth Financial Data Visualization Choosing Investment Platforms Sudarshan Chemical Industries Limited has announced the sale of its step-down subsidiary, VP4 Frankfurt GmbH, to Celanese Corporation. This strategic divestment is aimed at sharpening Sudarshan's focus on its core pigments business. VP4 Frankfurt, which manufactures intermediates like Diketene, was acquired as part of the Heubach Group acquisition. The transaction allows Sudarshan to concentrate on its strengths in color solutions and specialized pigments. Leasing Office Equipment Strategic divestment for core focus. Sudarshan Chemical Industries Limited announced today the sale of its step-down subsidiary, VP4 Frankfurt GmbH, to Celanese Corporation, USA. This strategic move is designed to sharpen the company's focus on its core pigments business, a key area where Sudarshan aims to create maximum value for its customers. VP4 Frankfurt's business and strategic alignment. VP4 Frankfurt GmbH is primarily engaged in the manufacture of certain intermediates, notably Diketene. It operates as a tolling operator for Nutrinova, an affiliate of Celanese Corporation and Mitsui & Co. Japan. VP4 Frankfurt became part of Sudarshan's portfolio through its acquisition of the Heubach Group. The divestment is considered a strategic step that strengthens Sudarshan's operational position. Benefits of the transaction. The transaction aligns VP4 Frankfurt more closely with its principal customer, Nutrinova, which is a producer of food industry additives. While VP4 Frankfurt serves Nutrinova as its main customer, only a small portion of its output was used by Sudarshan for captive consumption. Following the completion of the transaction, Nutrinova will continue to supply Sudarshan with the necessary materials. This divestment is viewed as a positive outcome for the asset, its employees, and Sudarshan Chemical Industries Limited. Leadership commentary. Rajesh Rathi, Chairman & Managing Director of Sudarshan Chemical Industries Limited, stated, "The sale of VP4 Frankfurt is a strategic step in sharpening our focus. Pigments and colorants are where we create the most value for our customers. VP4 is a well-run business with a strong team, and it now moves to the company it already serves. That is the right outcome for the asset, for its employees, and for Sudarshan." About Sudarshan Chemical Industries Ltd. Sudarshan Chemical Industries Ltd is a global leader in color solutions and specialized pigments, serving customers in over 120 countries. Headquartered in Pune and Frankfurt, the company offers a broad portfolio of organic, inorganic, and pearlescent pigments used across coatings, plastics, inks, cosmetics, and other applications. Supported by more than 3,900 employees and 20 manufacturing and R&D sites worldwide, Sudarshan continues to set benchmarks in color quality, performance, and sustainability. on September 1, 2026 Sun pharma: joins white house ceremony on US medicines pricing commitments. UltraTech cement: commences production at bharuch wires & cables plant. Discover more Market Research Reports Board Meeting Summaries